456 Comparisons of clinical outcomes in women with advanced ovarian cancer treated with frontline intraperitoneal versus dose-dense platinum/paclitaxel chemotherapy without bevacizumab
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.